Clinical benefits and improved quality of life for longer, result of capivasertib with fulvestrant in metastatic breast cancer
WritingThe magazine The Lancet Oncology has published this Wednesday the conclusions of the study led by the VHIO researcher and oncologist at the Vall d’Hebron University Hospital Mafalda Oliveirawhich analyzes the results reported by patients with locally advanced or metastatic breast cancer con receptor hormonal RH+ y HR2- alterations in the Akt signaling pathway, treated … Read more